Unequal Behaviour between Hydrolysable Functions of Nirmatrelvir under Stress Conditions: Structural and Theoretical Approaches in Support of Preformulation Studies

Nirmatrelvir is an antiviral drug approved for the treatment of COVID-19. The available dosage form consists of tablets marketed under the brand name PAXLOVID^®. Although knowledge of nirmatrelvir’s intrinsic stability may be useful for any potential development of other pharma...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Philippe-Henri Secretan, Maxime Annereau, Willy Kini-Matondo, Bastien Prost, Jade Prudhomme, Lina Bournane, Muriel Paul, Najet Yagoubi, Hassane Sadou-Yayé, Bernard Do
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Subjects:	selective hydrolysis ab initio calculations DFT mass spectrometry degradation products preformulation studies
Online Access:	https://www.mdpi.com/1999-4923/14/8/1720